Conventionally sourced from shellfish with allergy concerns and supply constraints, N-acetylglucosamine(NAG) is now being redefined through corn-based fermentation technology. This revolutionizing production, establishes the first truly plant-based (vegan) glucosamine, completely free from allergenic concerns.
1. Raw Material Innovation / Technological Breakthrough: From Ocean to Farmland
(1)Uses non-GMO corn glucose instead of crustacean sources (compliant with FDA 21 CFR 101.22)
(2) Microbial fermentation achieves >99.5% purity (HPLC-verified)
(3) Allergen test results: Crustacean protein residue <0.001 ppm
2.Production Process Comparison
Parameter |
Plant Fermentation |
Traditional Extraction |
Production Cycle |
3–5 days |
2–3 weeks |
Yield Efficiency |
8 MT/1,000 MT corn |
1.2 MT/1 MT crustacean |
Carbon Footprint |
0.8 kg CO₂e/kg |
2.4 kg CO₂e/kg |
3. Product Advantages: Safer, More Effective Joint Support
(1) Triple Safety Assurance
① Certified vegan (IVF-Vegan Standard)
② Halal/Kosher dual-certified
③ Zero marine heavy metals (lead/mercury undetected)
(2) Clinical Efficacy Data
① 22% higher bioavailability (Nutrition Journal 2024 study)
② 18% greater joint discomfort relief in 6 weeks (n=500 RCT)
As a flagship product in the global vegan trend, plant-based NAG retains the core benefits of cartilage repair and joint lubrication while aligning with clean-label demands. This innovation now meets 5% of global joint health needs annually. With accelerating aging populations, this green molecule—combining technology and wellness—is driving the health industry toward "green manufacturing" and may reshape the billion-dollar nutrition market.